Lactocetin is a name used in patent literature for a molecular complex involving lactoferrin and quercetin. Lactoferrin is an iron-binding glycoprotein, while quercetin is a naturally occurring flavonoid found in various plant sources. Research into their combination has explored molecular interactions, physicochemical characteristics, and potential formulation approaches.
Lactocetin may be of interest to research organizations, nutraceutical developers, formulation scientists, and ingredient companies investigating specialized ingredient complexes. Its precise composition and suitability for a particular application depend on the grade, manufacturing process, analytical results, and supporting documentation supplied with the material.
The published patent literature describes the preparation and characterization of lactoferrin–quercetin complexes using processes such as grinding or milling. It discusses multiple molar ratios and analytical characterization, including differential scanning calorimetry (DSC).
These patent examples should not automatically be interpreted as the specifications of every commercially available Lactocetin product. Buyers should confirm the exact ingredient identity, lactoferrin source, quercetin form, component ratio, processing method, purity, and batch-specific quality data with the relevant manufacturer.
The lactoferrin–quercetin combination may be investigated for nutraceutical formulation research, ingredient compatibility, solid-state characterization, and the development of suitable oral dosage forms. Any intended application should be supported by evidence appropriate to the specific finished product and its jurisdiction.
Patent descriptions of proposed applications do not establish that a product is clinically effective, approved for treating infections, or suitable for administration by every route described in a patent. Lactocetin should not be promoted as a proven treatment or preventive product for COVID-19 or other viral diseases without appropriate clinical evidence and regulatory authorization.
For commercial evaluation, request the current Technical Data Sheet (TDS), Certificate of Analysis (CoA), ingredient composition, identification and assay methods, microbiological results where relevant, contaminant testing, storage conditions, shelf life, packaging details, and applicable regulatory documentation.
Specifications should be matched to the exact grade and batch. Do not rely on a patent example or a general description as a substitute for the supplier's approved product specification.
Mediocon Inc. works with pharmaceutical and nutraceutical ingredient sourcing. Buyers interested in Lactocetin can contact Mediocon to confirm whether the exact material is available, request technical documents, and discuss grade, quantity, packaging, and delivery requirements.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Lactocetin – Product Details and Specifications | Mediocon Inc. and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Lactocetin – Product Details and Specifications | Mediocon Inc. is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance